Technical Analysis for RFL - Rafael Holdings, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
B | 1.83 | -1.08% | -0.02 |
RFL closed down 1.08 percent on Friday, November 1, 2024, on 31 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It was able to find support at its 50 day moving average. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
50 DMA Support | Bullish | 0.00% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Gapped Down | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
MACD Bearish Centerline Cross | Bearish | -1.08% | |
New Downtrend | Bearish | -1.08% | |
50 DMA Support | Bullish | -1.08% |
Alert | Time |
---|---|
10 DMA Resistance | about 19 hours ago |
Possible NR7 | about 19 hours ago |
Possible Inside Day | about 19 hours ago |
Rose Above 10 DMA | about 21 hours ago |
Down 2 % | about 21 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 12/12/2024
Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells.
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Cancer Cell Millennium Pharmaceuticals
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Cancer Cell Millennium Pharmaceuticals
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 2.5 |
52 Week Low | 1.29 |
Average Volume | 45,186 |
200-Day Moving Average | 1.66 |
50-Day Moving Average | 1.80 |
20-Day Moving Average | 2.00 |
10-Day Moving Average | 1.85 |
Average True Range | 0.11 |
RSI (14) | 45.36 |
ADX | 29.56 |
+DI | 21.33 |
-DI | 24.17 |
Chandelier Exit (Long, 3 ATRs) | 2.18 |
Chandelier Exit (Short, 3 ATRs) | 2.11 |
Upper Bollinger Bands | 2.35 |
Lower Bollinger Band | 1.64 |
Percent B (%b) | 0.26 |
BandWidth | 35.26 |
MACD Line | -0.01 |
MACD Signal Line | 0.03 |
MACD Histogram | -0.0317 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.92 | ||||
Resistance 3 (R3) | 1.92 | 1.89 | 1.91 | ||
Resistance 2 (R2) | 1.89 | 1.87 | 1.89 | 1.90 | |
Resistance 1 (R1) | 1.86 | 1.85 | 1.88 | 1.86 | 1.89 |
Pivot Point | 1.83 | 1.83 | 1.84 | 1.83 | 1.83 |
Support 1 (S1) | 1.80 | 1.81 | 1.82 | 1.80 | 1.77 |
Support 2 (S2) | 1.77 | 1.79 | 1.77 | 1.76 | |
Support 3 (S3) | 1.74 | 1.77 | 1.76 | ||
Support 4 (S4) | 1.74 |